Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Apitoxin is a new biological drug for pain & inflammation and arthritis, approved by the Korean FDA on May 3, 2003 after 14 years of preclinical, animal, and phase I, II & III clinical studies More
Our client is an academic institution that has developed a unique anti-microbial monocaprin emulsion with key cleaning solvent properties indicated primarily for the preparation and protection of food and cosmetics. More
Biotechnology Product for Wound Healing More
Scientists at the forefront of regenerative medicine based at the Biomatcell Vinn Excellence Center of Biomaterials have identified this small molecule platform with these unique osteogenic differentiating properties and are now looking to develop them. More
The ‘green technology’ allows the extraction of cosmetically active compounds from plants using root exudation without harming the plants involved. More
A monoclonal antibody against GluR3B, a peptide found in epilepsy patients, and especially in patients suffering from intractable, resistant forms of the disease, could be used in diagnosis kits as well as in drug development for this form of "autoimmune. More
Ob-X is composed of herbal extracts, and reduced body and adipose tissue weight and number and size of lipid vacuoles in the liver in animal studies; reduced body weight, waist circumference and visceral fat in human studies More
Cripto-1 expression increases the expression of TNF-alpha in CD4+ T cells in tissues affected by chronic inflammatory disease. More
Guided Bone Regeneration Membrane in Dental Surgery More
Direct gene amplification using AnyDirect solution gives reliable results from crude biospecimens without DNA isolation or any instrument. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Dec 2008 - 35 pages - $200
Dec 2010 - 15 pages - $500
Dec 2010 - 16 pages - $500
May 2011 - 15 pages - $250
Dec 2010 - 25 pages - $500
Dec 2007 - 65 pages - $3,395
Apr 2008 - 39 pages - $495
Sep 2011 - 30 pages - $250
Sep 2011 - 37 pages - $250
Mar 2011 - 26 pages - $500
Your selection
- Industry sector
- Biotechnology del
Browse By
- Industry sector
- Assay systems
- Diagnostic test systems
- Gene therapy
- Human diagnostics
- Human therapeutics
- Nanotechnology
- Other
- Research supplies
- Stem cells
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us